[1]
2025. Evaluating the Long-Term Cardiovascular Effects of SGLT2 Inhibitors in Type 2 Diabetes Mellitus Patients. ICMERD-International Journal of Medical Science (ICMERD-IJMS). 6, 4 (Jul. 2025), 1–13.